Landscapes / Companies

Aragon Pharmaceuticals, Inc. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
 
Next date
Apalutamide, Phase 3 trial completes
Drugs
2
in active trials
Trials
6 active
11 since 2021

Drugs2

DrugHow it worksPartnerStageNext dateDetails
—
Johnson & Johnson (Janssen)
Approved 1 Mar 2027Phase 3 trial completes
Cytochrome P450 17A1 inhibitor
Johnson & Johnson (Janssen)
Approved —

About

SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 20 Nov 2026 Industry-sponsored drug trials since 2021

Follow Aragon Pharmaceuticals, Inc.

Following is part of Solo: you see every change to Aragon Pharmaceuticals, Inc. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in